Medpace Holdings Inc vs IAC/Interactivecorp — how do they compare? Medpace Holdings Inc trades at $597.39 (market cap $16.90B), while IAC/Interactivecorp trades at $40.21 (market cap $2.97B). The key difference: Medpace Holdings Inc is far larger — about 5.7× IAC/Interactivecorp's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, IAC/Interactivecorp nearer its low. Which is the better fit depends on your goals.
| MEDP | PPLI | |
|---|---|---|
Market Cap | $16.90B | $2.97B |
Sector | Technology | Media |
52-Week High | $620.59 | $47.62 |
52-Week Low | $393.42 | $31.52 |
Enterprise Value | $16.52B | $3.28B |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.
MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.
PPLI trades at $40.60, down 0.15% on the day, with a bearish technical signal. Recent Q2 2026 earnings beat expectations at $6.77 EPS, driven by digital growth and MGM investment gains. The company shows strong profitability margins but volatile cash flows, with a net cash outflow of $820.42 million in 2025. Valuation ratios appear attractive with a P/E of 6.76 and P/B of 0.59.
Outlook is mixed: analyst consensus is bullish with a $60.50 price target, but risks include inconsistent earnings, high debt, and negative operating cash flow. The stock offers value potential if turnaround plans succeed, yet faces execution challenges in monetizing non-core assets.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →